Harel Insurance Investments & Financial Services’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
Other funds holding ALNY
Harel Insurance Investments & Financial Services's ALNY Position: Q1 2021 in Review
Harel Insurance Investments & Financial Services sold out of Alnylam Pharmaceuticals (ALNY) in Q1 2021, closing a stake of 933 shares — an estimated $390K sold.
Harel Insurance Investments & Financial Services first reported a position in ALNY in Q4 2015 and held it in 16 quarters. The position peaked at $390K in Q4 2020. 391 funds tracked by Wall St. Rank hold ALNY as of Q1 2021.
- Harel Insurance Investments & Financial Services reported no remaining Alnylam Pharmaceuticals position as of Q1 2021 after selling out during the quarter.
- Harel Insurance Investments & Financial Services sold 933 Alnylam Pharmaceuticals shares in Q1 2021, an estimated $390K.
- Harel Insurance Investments & Financial Services first reported a position in Alnylam Pharmaceuticals in Q4 2015 and held it in 16 quarters.
- Harel Insurance Investments & Financial Services's Alnylam Pharmaceuticals position peaked at $390K in Q4 2020.
- 391 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q1 2021.
Based on Harel Insurance Investments & Financial Services's 13F filing for Q1 2021, filed 27 Apr 2021.